1. Home
  2. HTCR vs SABS Comparison

HTCR vs SABS Comparison

Compare HTCR & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • SABS
  • Stock Information
  • Founded
  • HTCR 2009
  • SABS 2014
  • Country
  • HTCR Japan
  • SABS United States
  • Employees
  • HTCR N/A
  • SABS N/A
  • Industry
  • HTCR EDP Services
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • SABS Health Care
  • Exchange
  • HTCR Nasdaq
  • SABS Nasdaq
  • Market Cap
  • HTCR 16.9M
  • SABS 15.8M
  • IPO Year
  • HTCR 2022
  • SABS N/A
  • Fundamental
  • Price
  • HTCR $1.07
  • SABS $2.58
  • Analyst Decision
  • HTCR
  • SABS Strong Buy
  • Analyst Count
  • HTCR 0
  • SABS 4
  • Target Price
  • HTCR N/A
  • SABS $9.50
  • AVG Volume (30 Days)
  • HTCR 2.4M
  • SABS 103.0K
  • Earning Date
  • HTCR 11-13-2025
  • SABS 11-05-2025
  • Dividend Yield
  • HTCR N/A
  • SABS N/A
  • EPS Growth
  • HTCR N/A
  • SABS N/A
  • EPS
  • HTCR N/A
  • SABS N/A
  • Revenue
  • HTCR $29,625,381.00
  • SABS $114,698.00
  • Revenue This Year
  • HTCR N/A
  • SABS N/A
  • Revenue Next Year
  • HTCR $3.52
  • SABS N/A
  • P/E Ratio
  • HTCR N/A
  • SABS N/A
  • Revenue Growth
  • HTCR 72.95
  • SABS N/A
  • 52 Week Low
  • HTCR $0.39
  • SABS $1.00
  • 52 Week High
  • HTCR $3.38
  • SABS $6.60
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 58.33
  • SABS 67.26
  • Support Level
  • HTCR $0.91
  • SABS $2.05
  • Resistance Level
  • HTCR $1.09
  • SABS $2.18
  • Average True Range (ATR)
  • HTCR 0.15
  • SABS 0.13
  • MACD
  • HTCR -0.01
  • SABS 0.03
  • Stochastic Oscillator
  • HTCR 57.33
  • SABS 91.67

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: